🏛️ Verified NIH Record • Updated 2026-07-15
Pancreatic Cancer Detection Consortium (NCT06388967)
🟢 Recruiting Interventional Protocol 📊 Observational Clinical Research Sponsor: City of Hope Medical Center
🩺 Plain-English Summary (8th-Grade Level)
This study aims to prospective validate an exosome-based miRNA signature for noninvasive and early detection of pancreatic ductal adenocarcinoma.
Who can join: To join this study, participants generally need to meet the listed inclusion criteria (3 items) and avoid the listed exclusions (2 items).
Location: Translational Genomics Research Institute — Phoenix, Arizona
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistCheck every box below. If you can check all of them, you may meet the study's basic screening requirements (final eligibility is confirmed by the site team).
Usually NOT eligible if any of the following apply:
- Exclusion Criteria:
- Lack of written informed consent.
🔍 Extracted verbatim from the official NIH eligibility criteria. Always confirm with the study coordinator.
📍 All Participating Trial Locations (11 Sites)
- Translational Genomics Research Institute — Phoenix, Arizona
- Honorhealth — Scottsdale, Arizona
- City of Hope Medical Center — Monrovia, California
- Hoag Center — Newport Beach, California
- OSF HealthCare — Peoria, Illinois
- Ochsner Medical Center — Jefferson, Louisiana
- Atlantic Health System — Morristown, New Jersey
- Piedmont Medical Center — Rock Hill, South Carolina
- Medical College of Wisconsin — Milwaukee, Wisconsin
- Nagoya University — Nagoya,
- Asan Medical Center — Seoul,
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.